1,130
Participants
Start Date
February 5, 2015
Primary Completion Date
March 8, 2021
Study Completion Date
March 8, 2021
Pertuzumab
Study protocol does not specify/enforce any particular dosage regimen. Pertuzumab will be administered according to standard of care and in line with current SmPC/local labelling.
National Health Insurance Service Ilsan Hospital, Gyeonggi-do
Seoul National University Bundang Hospital, Seongnam-si
Hallym University Sacred Heart Hospital, Gyeonggi-do
Soonchunhyang University Bucheon Hospital, Gyeonggi-do
St. Vincent's Hospital, Gyeonggi-do
Ajou University Medical Center, Gyeonggi-do
Catholic Univ. of Incheon St.Mary's Hospital, Incheon
Inha University Hospital, Incheon
Chungnam National University Hospital, Daejeon
Kyungpook National University Chilgok Hospital, Daegu
Keimyung University Dongsan Medical Center, Daegu
Ulsan University Hosiptal, Ulsan
Inje university Haeundae Paik Hospital, Busan
Pusan National University Hospital, Busan
Kosin University Gospel Hospital, Busan
Pusan National University Yangsan Hospital, Gyeongsangnam-do
Wonkwang University School of Medicine & Hospital, Jeonlabuk-do
Chonnam National University Hwasun Hospital, Jeollanam-do
The Catholic University of Korea Bucheon St. Mary's Hospital, Gyeonggi-do
Catholic Kwandong University International St. Mary'S Hospital., Incheon
Gil Hospital. Gachon University, Incheon
Samsung Medical Center, Seoul
Inje University, Sanggye-Paik Hospital, Seoul
Korea Cancer Center Hospital of Korea Institute of Radiological and Medical Sciences, Seoul
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Konkuk University Medical Center, Seoul
Gangdong Kyung Hee University Hospital, Seoul
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Seoul St Mary's Hospital, Seoul
ChungAng University Hospital, Seoul
Yeouido St. Mary's Hospital, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Korea University Guro Hospital, Seoul
SMG-SNU Boramae Medical Center, Seoul
Hoffmann-La Roche
INDUSTRY